Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 844.04M P/E - EPS this Y 14.80% Ern Qtrly Grth -
Income -270.46M Forward P/E -8.25 EPS next Y 62.70% 50D Avg Chg -33.00%
Sales 341.82M PEG -0.16 EPS past 5Y - 200D Avg Chg -67.00%
Dividend N/A Price/Book 3.31 EPS next 5Y 30.00% 52W High Chg -85.00%
Recommedations 1.70 Quick Ratio 1.97 Shares Outstanding 319.70M 52W Low Chg 80.00%
Insider Own 29.75% ROA -17.57% Shares Float 202.24M Beta 1.57
Inst Own 50.20% ROE -532.08% Shares Shorted/Prior 45.23M/43.74M Price 2.64
Gross Margin 53.30% Profit Margin -79.27% Avg. Volume 5,735,445 Target Price 14.83
Oper. Margin -48.40% Earnings Date May 4 Volume 9,155,281 Change 18.92%

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.

AMRS Chatroom

User Image tradechill Posted - 51 seconds ago

$AMRS JP morgan and intel both rejected compensation packages for their CEOs. If our big holders vote for melos package that would be a shame.

User Image EframYou Posted - 12 minutes ago

$AMRS for all the idiots w/ poor listening skills, AMRS is not selling molecules. they're selling the licensing rights to the molecules which is expected to generate $250mil or so. they will continue to manufacture them and will profit on the manufacturing margins as well. they will still own the molecules. this is much, much better than selling molecules.

User Image WantedToRetireEarly Posted - 44 minutes ago

$AMRS $ENPH $IBRX $TSLA This is in line with what Goldman and others have been saying. 30% chance by next year appears to be current consensus: https://finance.yahoo.com/news/economist-recession-risk-is-increasing-especially-for-2023-193734146.html As the market’s downward slide continues following a hawkish Federal Reserve statement Tuesday afternoon, economists have downgraded their forecasts for the economy in 2023. “While we don’t necessarily have a recession in our forecasts, we do see the risk of a recession increasing,” said Beth Ann Bovino, Chief U.S. Economist for S&P Global Ratings. “We now have it at about 30%; we see the risk go much larger in 2023 when those cumulative rate hikes from the Fed to attack inflation start to weigh on mortgage payments and monthly payments.” Bovino joined Yahoo Finance Live on Tuesday to discuss recession risks in light of the ongoing Federal Reserve rate hikes as well the latest economic data on the consumer economy.

User Image The_Perfect_Wave Posted - 56 minutes ago

$AMRS Friday's market winners! AMRS | 18.92% [Search Criteria] Symbol closed 10% or more in gain.

User Image sandhillinvestor Posted - 1 hour ago

$AMRS is it me or do the $3 2023 calls seem like a no brainer?

User Image deporte1800 Posted - 1 hour ago

$AMRS 2.64 quote price arrow up+0.42 (+18.92%) Volume 9,142,430 Big news to come in the next few days, all Amyris investors should be very attentive to the conferences on the 23rd, 24th and 25th.

User Image AndItsGome Posted - 1 hour ago

$AMRS cash burn question that might be useful to know - With BB coming online and the capacity to ferment various molecules “on-demand”, is the procurement of all the various raw ingredients built into the cash burn projections? Staffing? Will there be an inventory build up initially, or are ingredients ordered on-demand?

User Image Dcrolltide Posted - 1 hour ago

$AMRS new HOD into close. LFG!!!

User Image tickeron Posted - 2 hours ago

This is why Hedge Funds use A.I. $AMRS in -37.98% Downtrend, declining for three consecutive days on May 11, 2022. View odds for this and other indicators: https://srnk.us/go/3673042

User Image deporte1800 Posted - 2 hours ago

$AMRS A few years ago I was one of the shareholders who was in favor of selling 49-51% of Biossance, as I wrote on this board. Fortunately, the directors of Amyris did not follow my indications. It will always be better to sell one or two molecules a year until Amyris is self-sufficient, than to sell one of the brands. Why? Brands generate recurring revenues and profits year after year and the sale of molecules is a one-time income. In addition Amyris can generate 2-4 molecules per year, this will make it impossible for Amyris in the medium to long term to have the capacity with its ingredient plant to be able to produce such a quantity. Licensing contracts and royalties will be the best solution when Amyris has more than 20 molecules. Therefore, IMO. Better to sell molecules or license the IP and not sell any brands at all.....

User Image deporte1800 Posted - 2 hours ago

$AMRS John Doer with 30% of Amyris has an entry price at $2.87. But we must also remember the price of other large investors who invested in Amyris at a price of between $12-15. They invested large amounts of millions expecting to make a lot of money, it was not that long ago. Some of you remember that, don't you? they will invest and average, they will drive the price up in a very important way and in a very short term.

User Image WantedToRetireEarly Posted - 3 hours ago

$AMRS Slowdown in on-line sales is real. I hope Melo's and Han's projections were not overly optimistic: Shares of Wayfair were rising Tuesday following a report that the company could be implementing a 90-day corporate hiring freeze as it navigates rising costs and slowing demand for e-commerce. A spokesperson for Wayfair (ticker: W ) told Bloomberg that the company sees “agreat deal of uncertainty in the overall economy.” The company is the latest to impose a hiring pause or slowdown, joining companies such as Coinbase Global (Coin), Twitter ( TWTR ), Meta Platforms ( FB ), and Uber Technologies (UBER) in scaling back headcount. Online spending slowed in April, down 6.8% in March with the progression of the economic reopening, according to Adobe data. That slowdown was salient across the first-quarter results of various e-commerce companies, with even Amazon.com (AMZN) reporting a slowdown in online sales.

User Image WantedToRetireEarly Posted - 3 hours ago

$AMRS $ENPH $TSLA $SOFI A really excellent article all investors should read but especially younger investors who have not been through bear markets before. I agree with him that if this is a bear market and not just a really nasty correction (already a bear market for the NASDAQ) we have a long way to go still before there is a real bottom. The only stock I own that has seen a true Bear Market type of capitulation recently is $AMRS. That thunderous sell off around earnings where it lost 50% in two days is very typical of a real bottom. Stock is now up 60% from that $1.50 low. Unfortunately, so many unprofitable growth stocks are down 70% already but in the final stages of a bear, could go down 90%. Saw it after the .com crash. Read and share. https://www.marketwatch.com/story/stock-investors-are-now-starting-to-feel-the-5-stages-of-bear-market-grief-11652774279?mod=moremw_bomw

User Image CaptainConfusion Posted - 3 hours ago

$AMRS Make it so # 1...

User Image keepitrealJM Posted - 4 hours ago

$AMRS picked up additional 620 shares at 2.39

User Image ErnestineSaunders Posted - 4 hours ago

$AMRS Best stocks to buy this week,,,. hot-stocks.investorplace.online

User Image Vertical_Capital Posted - 4 hours ago

$IBRX Well if you believe in the joint venture and T-cell vaccine with $AMRS then you better buy shares there if you haven't already. I was lucky enough to buy 20,000 shares under $1.90 last week on the dip. Retracement in $AMRS is unreal at this point.

User Image AaronGLow Posted - 4 hours ago

$AMRS going to see a +75% day soon. 4.20 here we come

User Image knotrek19 Posted - 4 hours ago

$AMRS so upset i didnt buy at 1.60 aaarg. But let s move forward. Average 5 usd is waiting

User Image PltrWoof Posted - 4 hours ago

$AMRS double top on the daily? 😮‍💨

User Image firewire11 Posted - 5 hours ago

$AMRS I'm really liking the Jan 2023 Call options here , all strikes from $2 to $7 .... between now and then we get two more earnings calls, some molecule sales, Possible Biosance sale, hopefully a Novvi Sale, Plus a Santa Clause rally and then the Jan Effect on small caps. Any combination of these could have us magnitudes higher .... i didn't even mention the impending 'rip your face off' short squeeze or the possibility of new analyst coverage.

User Image ErnestineSaunders Posted - 5 hours ago

$AMRS Top stocks to watch today,,.. hot-stocks.investorplace.online

User Image SpaghettiandMeatballs Posted - 6 hours ago

$AMRS good god they are trying so hard to short this down on level 2. HOLD

User Image EframYou Posted - 6 hours ago

$AMRS interesting https://www.zerohedge.com/covid-19/genetically-edited-food-next-stage-great-reset

User Image SpaghettiandMeatballs Posted - 6 hours ago

$AMRS lol how does this go from $2.20 to $2.64 to $2.38. This market is blackout drunk

User Image tradechill Posted - 6 hours ago

$AMRS 15 min chart is ugly after that 1st candle

User Image jthottam Posted - 7 hours ago

$AMRS NEXT STOCK TALK WITH "IN THE RUFF RESEARCH" #34: 7pm CST - Sunday, May 22nd Companies covered on this Call: Amyris and Lithium Americas (Additional Updates on: Schwazze Priority Technology Clipper Realty) ************************************* Hi Gang, We will cover a few things: 1. 30 minutes - State of the Union (i.e., Macroeconomics, COVID Implications, upcoming milestones for the market and economy) 2. 60 minutes - Review of Latest Articles (e.g., Draft of Lithium Americas and Prelim Info on Amyris) 3. 30 - Some Quick updates on other Companies we follow (e.g., Schwazze: SHWZ; Priority Technology: PRTH; Clipper: CLPR) ********************************* Webcast link can be found on our facebook page: "In the Ruff Research". ********************************* WHILE STOCKS WILL BE DISCUSSED IT IS UP TO YOU TO DO YOUR OWN RESEARCH, MAKE YOUR OWN DECISIONS, AND INVEST AT YOUR OWN RISK.

User Image SubstitutedPinions Posted - 7 hours ago


User Image Tom_Cruise_Control Posted - 7 hours ago

$AMRS visited girls family over the weekend....nothing but JVN in their bathrooms. love to see it

User Image DBA3 Posted - 7 hours ago

$AMRS Hot damn, I tried to snag a few more shares below 2.50 this morning. They were gone inside 8 mins after open.

Analyst Ratings
Roth Capital Buy Aug 6, 21
Oppenheimer Outperform Aug 6, 21
HC Wainwright & Co. Buy Aug 6, 21
HSBC Buy Jun 1, 21
Roth Capital Buy Mar 3, 21
H.C. Wainwright Buy Mar 3, 21
Roth Capital Buy Feb 26, 21
Cowen & Co. Outperform Jan 6, 21
Cowen & Co. Market Perform Nov 25, 20
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Kung Frank Director Director Apr 15 Option 4.51 3,156,446 14,235,571 938,416 04/15/21